Polycarbophil
Polycarbophil is a hydrophilic polymer used mainly as a bulk-forming laxative to relieve constipation and as a stool-regulating agent in some patients with diarrhoea or irritable bowel syndrome. It absorbs water in the gastrointestinal tract, forming a gel that increases stool bulk and helps regulate stool consistency and bowel movements. It is available in oral tablet and chewable tablet formulations, with adequate water intake essential during use. Common side effects include bloating, gas, abdominal discomfort, and constipation. Taking it without sufficient fluid may cause choking or intestinal or oesophageal obstruction, particularly in people with swallowing difficulties or intestinal narrowing. It may also affect the absorption of other oral medicines, so appropriate dose separation should be followed according to product instructions.
Polycarbophil was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Polycarbophil, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Polycarbophil from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Polycarbophil, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
